NL9202091A - Heterocyclische derivaten. - Google Patents

Heterocyclische derivaten. Download PDF

Info

Publication number
NL9202091A
NL9202091A NL9202091A NL9202091A NL9202091A NL 9202091 A NL9202091 A NL 9202091A NL 9202091 A NL9202091 A NL 9202091A NL 9202091 A NL9202091 A NL 9202091A NL 9202091 A NL9202091 A NL 9202091A
Authority
NL
Netherlands
Prior art keywords
alkyl
formula
group
alkoxy
halogen
Prior art date
Application number
NL9202091A
Other languages
English (en)
Dutch (nl)
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Publication of NL9202091A publication Critical patent/NL9202091A/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NL9202091A 1991-12-04 1992-12-02 Heterocyclische derivaten. NL9202091A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919125842A GB9125842D0 (en) 1991-12-04 1991-12-04 Heterocyclic derivatives
GB9125842 1991-12-04

Publications (1)

Publication Number Publication Date
NL9202091A true NL9202091A (nl) 1993-07-01

Family

ID=10705730

Family Applications (1)

Application Number Title Priority Date Filing Date
NL9202091A NL9202091A (nl) 1991-12-04 1992-12-02 Heterocyclische derivaten.

Country Status (10)

Country Link
JP (1) JPH05255327A (it)
BE (1) BE1005473A3 (it)
CA (1) CA2082668A1 (it)
DE (1) DE4239440A1 (it)
FR (1) FR2684672A1 (it)
GB (2) GB9125842D0 (it)
IE (1) IE922785A1 (it)
IT (1) IT1256320B (it)
NL (1) NL9202091A (it)
ZA (1) ZA928742B (it)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5439911A (en) * 1992-12-28 1995-08-08 Shionogi & Co., Ltd. Aminopyrimidine derivatives and their production and use
ES2126061T3 (es) * 1993-03-24 1999-03-16 American Home Prod Piridopirimidinas substituidas como antihipertensores.
KR100300566B1 (ko) * 1994-09-17 2001-11-22 조생현 피리미디논유도체와그의제조방법및용도
US6440965B1 (en) * 1997-10-15 2002-08-27 Krenitsky Pharmaceuticals, Inc. Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system
US6583148B1 (en) 1999-04-08 2003-06-24 Krenitsky Pharmaceuticals, Inc. Neurotrophic substituted pyrimidines
EP1303495B1 (en) 2000-07-24 2010-05-26 Krenitsky Pharmaceuticals, Inc. Substituted 5-alkynyl pyrimidines having neurotrophic activity
GB0117396D0 (en) 2001-07-17 2001-09-05 Glaxo Group Ltd Chemical compounds
GB0308208D0 (en) 2003-04-09 2003-05-14 Glaxo Group Ltd Chemical compounds
DE60303238T2 (de) * 2003-04-25 2006-09-14 Actimis Pharmaceuticals, Inc., La Jolla Pyrimidin-Essigsäure Derivate geeignet zur Behandlung von CRTH2-bedingten Krankheiten
PL1718649T3 (pl) 2004-01-31 2009-11-30 Actimis Pharmaceuticals Inc Pochodne kwasu imidazo[1,2-c]pirymidynylooctowego
TW200922587A (en) 2007-09-25 2009-06-01 Actimis Pharmaceuticals Inc Alkylthio pyrimidines as CRTH2 antagonists
MX2010003178A (es) 2007-09-25 2010-04-30 Actimis Pharmaceuticals Inc Primidinas sustituidas con 2-s-bencilo como antagonistas de crth2.
KR102481705B1 (ko) * 2020-08-04 2022-12-27 연세대학교 산학협력단 트리아졸 유도체를 유효성분으로 포함하는 간 섬유증의 예방 또는 치료용 조성물
CN117136189A (zh) * 2021-04-09 2023-11-28 先声再明医药有限公司 泛素特异性蛋白酶1(usp1)抑制剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0424317A3 (en) * 1989-10-19 1991-09-25 Ciba-Geigy Ag Pyrimidines
IL99246A0 (en) * 1990-09-10 1992-07-15 Abbott Lab Angiotensin ii receptor antagonists and pharmaceutical compositions containing them
US5149699A (en) * 1991-10-24 1992-09-22 American Home Products Corporation Substituted pyridopyrimidines useful as antgiotensin II antagonists

Also Published As

Publication number Publication date
JPH05255327A (ja) 1993-10-05
ITMI922661A0 (it) 1992-11-20
ZA928742B (en) 1993-06-09
GB9125842D0 (en) 1992-02-05
IT1256320B (it) 1995-11-30
ITMI922661A1 (it) 1993-06-05
CA2082668A1 (en) 1993-06-05
BE1005473A3 (fr) 1993-08-03
DE4239440A1 (it) 1993-06-09
GB9225283D0 (en) 1993-01-27
FR2684672A1 (fr) 1993-06-11
IE922785A1 (en) 1993-06-16
GB2262096A (en) 1993-06-09

Similar Documents

Publication Publication Date Title
JP3010056B2 (ja) 窒素化合物
JP3120873B2 (ja) ピリジン誘導体
CA2037630C (en) Nitrogen-containing heterocylic compounds, their production and use
AU646473B2 (en) Process for the manufacture of biphenylcarbonitriles
US5217976A (en) 1,6-naphthyridone derivatives having angiotensin ii antagonist activity
FI95908B (fi) Menetelmä angiotensiini-II-antagonisteina aktiivisten 3-(2'-(substituoitu)bifen-4-yyli)metyyli-3H-imidatso/4,5-b/pyridiiniyhdisteiden valmistamiseksi
US7312330B2 (en) Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
JP2721147B2 (ja) α1−アドレナリン受容体拮抗剤としてのピリミジンジオン、ピリミジントリオン、トリアジンジオン、テトラヒドロキナゾリンジオン誘導体
US5126344A (en) Diazine derivatives and pharmaceutical use
FI93957B (fi) Menetelmä pyrimidiinien valmistamiseksi
US5236937A (en) Pyridinyl compounds which are useful as angiotensin ii antagonists
NL9202091A (nl) Heterocyclische derivaten.
CA2684563C (en) 2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl pyrazines and pyridines and 3-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-2-phenyl pyridines as 5-ht7 receptor antagonists
JPH04244080A (ja) ビフエニルカルボニトリルの製法
JPH0559042A (ja) 化学的方法
US5369114A (en) Biphenylene branched alkyleneoxy quinolines
JPH05140107A (ja) ピリジン化合物
EP2501233B1 (en) Quinazoline compounds
JP2529798B2 (ja) 4−ピリミジノン誘導体、その製造方法および治療への適用
CS88692A3 (en) Process for preparing quinoline derivatives
JPH05221989A (ja) 複素環式化合物
CA2054555A1 (en) Nitrogen compounds
JP3114073B2 (ja) アンジオテンシンii拮抗薬−含窒素異項環化合物
GB2234748A (en) 4-(substituted-phenyl)methoxy-quinoline derivitives having pharmacological activity
WO1994011379A1 (en) Heterocyclic compounds as angiotensin ii antagonists

Legal Events

Date Code Title Description
BV The patent application has lapsed